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PD-1 alters T-cell metabolic reprogramming by
inhibiting glycolysis and promoting lipolysis and
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During activation, T cells undergo metabolic reprogramming, which imprints distinct
functional fates. We determined that on PD-1 ligation, activated T cells are unable to engage
in glycolysis or amino acid metabolism but have an increased rate of fatty acid b-oxidation
(FAO). PD-1 promotes FAO of endogenous lipids by increasing expression of CPT1A, and
inducing lipolysis as indicated by elevation of the lipase ATGL, the lipolysis marker glycerol
and release of fatty acids. Conversely, CTLA-4 inhibits glycolysis without augmenting FAO,
suggesting that CTLA-4 sustains the metabolic proﬁle of non-activated cells. Because
T cells utilize glycolysis during differentiation to effectors, our ﬁndings reveal a metabolic
mechanism responsible for PD-1-mediated blockade of T-effector cell differentiation. The
enhancement of FAO provides a mechanistic explanation for the longevity of T cells receiving
PD-1 signals in patients with chronic infections and cancer, and for their capacity to be
reinvigorated by PD-1 blockade.
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M
aintenance of peripheral tolerance is essential for
homeostasis of the immune system. While central
tolerance mechanisms result in deletion of the majority
of self-reactive T cells, some T lymphocytes speciﬁc for self-
antigens escape this process and circulate in the periphery. PD-1
(CD279) and its ligands, PD-L1 (B7-H1; CD274) and PD-L2 (B7-
DC; CD273), play a vital role in peripheral tolerance1. PD-1
exerts its effects during the initial phase of activation of
autoreactive T cells on self-antigen presentation by DC. In
addition, PD-L1/2, expressed on non-haematopoietic tissues,
mediate tissue tolerance by suppressing tissue-reactive T cells2,3.
In contrast to its beneﬁcial role in maintaining self-tolerance, PD-
L1/2 expressed on malignant tumours or tumour-inﬁltrating
myeloid cells, mediate potent inhibitory signals on effector T cells
and have detrimental effects on anti-tumour immunity4,5.
Moreover, expression of PD-1 by ‘exhausted’ T cells in chronic
viral infections prevents the function of virus-speciﬁc T-cell
effectors and viral clearance6,7.
Naı¨ve T cells utilize oxidative phosphorylation (OXPHOS) for
energy generation. On activation via the T cell receptor, T cells
undergo a metabolic reprogramming to glycolysis, which is
required to support their growth, effector differentiation and
function8,9. Although energetically less efﬁcient, glycolysis is
required for cell growth. Conventional views suggest that
proliferating cells have a high rate of aerobic glycolysis, even
though there is sufﬁcient oxygen present to support OXPHOS, a
phenomenon known as the Warburg effect10. Signals from the
CD28 co-stimulatory pathway and the g-chain signalling
cytokines support activation, growth and expansion of T cells
by promoting this metabolic programme11,12. Divergence in the
metabolic reprogramming is critical to effectively imprint distinct
T-cell fates. This has been shown with the switch to glycolysis that
accompanies effector T-cell differentiation13 and the switch to
fatty acid b-oxidation (FAO) that accompanies the conversion of
T-effector to T-memory cells 14. Furthermore, enforcing FAO by
elevating AMPK activity or by inhibiting the mammalian target of
rapamycin resulted in increased numbers of memory
T cells14,15. It remains unknown whether the functional
outcome of PD-1 ligation is linked to T-cell reprogramming to
a speciﬁc metabolic pathway.
We investigated the metabolism of T cells receiving PD-1
signals and discovered that they were unable to engage in
glycolysis, glutaminolysis or metabolism of branched-chain
amino acids but displayed an increased rate of FAO. PD-1
promoted FAO of endogenous lipids by increasing the rate-
limiting enzyme of FAO, carnitine palmitoyl transferase (CPT1A)
and inducing lipolysis as determined by the increase of the major
triacylglycerol (TG) hydrolase desnutrin/adiposite triglyceride
lipase (ATGL) and release of fatty acids and glycerol. In addition
to increased FAO, T cells stimulated in the presence of PD-1
ligation possessed substantial spare respiratory capacity (SRC),
the extra mitochondrial capacity available in the cell to produce
energy under conditions of stress. Because burning fat has a
strong association with longevity in many cell types16–18, these
unexpected ﬁndings indicate that PD-1 ligation enables T cells to
survive as long-lived cells by utilizing a fat-based metabolism. In
contrast, CTLA-4 inhibited expression of the glutamine
transporters SNAT1 and SNAT2, and the glucose transporter
Glut1 and inhibited glycolysis without augmenting CPT1A and
FAO, suggesting that CTLA-4 maintains immune quiescence by
preserving the metabolic proﬁle of non-stimulated cells. PD-1
also altered the metabolic programme of pre-activated CD4þ
T cells and reprogrammed their metabolism from glycolysis to
FAO. Because PD-1 is expressed on activated T cells, which
employ glycolysis as the dominant source of energy generation
during differentiation into effectors, our ﬁndings indicate that
PD-1 ligation prevents effector cell development by altering
metabolic reprogramming of activated T cells by inhibiting
glycolysis and promoting FAO. Furthermore, the enhancement of
FAO suggests a mechanism responsible for the survival and
persistence of T cells receiving PD-1 signals in patients with
chronic infections and cancer and for their capacity to be
reinvigorated by PD-1 blockade.
Results
PD-1 abrogates transport and utilization of glucose. Activation
of naı¨ve CD4þ T cells is accompanied by effector differentiation,
which depends on aerobic glycolysis13. To examine the effects of
PD-1 on this physiologic mechanism of energy generation on
T-cell stimulation, we employed a previously established
experimental system19 of highly puriﬁed human CD4þ T cells
that were stimulated with magnetic beads conjugated with anti-
CD3, anti-CD28 monclonal antibodys (mAbs) and control
immunoglobulin-G (IgG; T cells co-stimulated (TCC)) or
magnetic beads conjugated with anti-CD3, anti-CD28 mAbs
and PD-L1-Ig fusion protein (T cells co-stimulatedþPD-1
(TCCþ PD1)), similar to an approach previously used in a mouse
cell system20. This approach has been designed to mimic the
physiologic conditions of primary T-cell activation by antigen-
presenting cells (APCs), which leads to engagement of PD-1 and
TCR/CD3 complex. Culture of T cells with simultaneous ligation
of PD-1 inhibited production of IFN-g (Fig. 1a), consistent with
the known effect of PD-1 signalling on T-cell effector responses.
To uptake glucose from the microenvironment, T cells must
upregulate the glucose transporter Glut1 (ref. 8). We determined
that Glut1 expression was upregulated in TCC, but Glut1
upregulation was less prominent in TCCþ PD1 cells (Fig. 1b). As
a consequence, TCC but not TCCþPD1 cells displayed robust
glucose uptake (Fig. 1c). Metabolite analysis in TCC cells showed
increased glucose utilization for glycolysis, as determined by
reduction of intracellular glucose and the pentose phosphate
pathway precursor 6-phosphogluconate and increase of the
glycolysis intermediate fructose 1,6-bisohosphate. This was
accompanied by depletion of glucose and signiﬁcant elevation
in the metabolic products of glycolysis, pyruvate and lactate, in
the corresponding culture supernatants (Fig. 1d, Supplementary
Fig. 1 and Supplementary Data 1 and 2). PD-1 largely blocked
glucose uptake and glycolysis as evidenced by unchanged levels of
glucose and diminished products of glycolysis in TCCþPD1
cultures (Fig. 1d). This effect of PD-1 was not only due to
inhibition of Glut 1 expression and glucose transport but also due
to inhibition of hexokinase 2 (HK2) (Fig. 1e), which catalyses the
ﬁrst step of glycolysis by converting glucose to glucose-6-
phosphate.
PD-1 inhibits amino acid transport and metabolism. T-cell
activation induces changes in amino acid metabolism21,22. Amino
acids serve as building blocks for protein synthesis, but also
contribute to many processes critical for dividing cells including
nucleotide synthesis, redox control and energy generation. We
examined whether PD-1 might alter the ability of T cells to utilize
amino acids. Glutamine is a key amino acid involved in numerous
processes23,24. Glutamine catabolism is tightly coupled to
various biosynthetic pathways but also generates the anaplerotic
substrate a-ketoglutarate, which can be metabolized through the
tricarboxylic acid cycle to generate citrate or pyruvate, a process
known as ‘glutaminolysis’24. The ﬁrst step of this process involves
conversion of glutamine to glutamate, which is subsequently
converted to a-ketoglutarate. The main glutamine transporters
are members of the SNAT family, SNAT1 and SNAT2, which
display a transient increase on T-cell activation25. Using real-time
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quantitative PCR, we determined that SNAT1 and SNAT2 were
transiently upregulated in TCC cells but induction was impaired
by PD-1 (Fig. 2a). Consistent with the elevated expression of
SNAT1 and SNAT2, TCC cells displayed ﬁndings of increased
glutamine uptake, as determined by decrease of glutamine in the
culture supernatants and increased glutaminolysis, as indicated by
reduction of intracellular glutamine and glutamate. PD-1
largely blocked glutamine uptake as indicated by glutamine
levels in the culture supernatants and inhibited glutaminolysis, as
determined by higher intracellular levels of glutamine and
glutamate in TCCþPD1 compared with TCC cells (Fig. 2b upper
row and Supplementary Data 1 and 2).
The branched-chain amino acids (BCAAs) valine, isoleucine
and leucine and their metabolites can be incorporated into
proteins and/or metabolized to meet energy demands. We
examined whether T cells receiving PD-1 signals might
metabolize BCAAs. Stimulation of T cells without PD-1 resulted
in signiﬁcant intracellular reduction in BCAAs. Reductions of
these BCAAs were also observed in the culture supernatants
and coincided with concomitant accumulation of the a-keto
acids 4-methyl-2-oxopentanoate, 3-methyl-2-oxovalerate and
3-methyl-2-oxobutyrate, metabolic products of BCAA catabolism
(Fig. 2b lower row, Supplementary Fig. 2 and Supplementary
Data 1 and 2). Although greater incorporation of BCAAs into
proteins to support growth in TCC cells might contribute to the
reduction in the levels of these amino acids, the concomitant
increase of their degradation products is consistent with increased
utilization to meet energy demands. In contrast, TCCþPD1 cells
displayed neither changes in the levels of BCAA nor changes in
the levels of the relevant a-keto acids (Fig. 2b lower row,
Supplementary Fig. 2 and Supplementary Data 1 and 2). Thus, on
PD-1 ligation T cells are unable to utilize BCAAs for energy
demands. In spite of the abrogated glycolysis and amino acid
utilization, these T cells remained viable and metabolically active
as determined by mitochondrial membrane potential (Fig. 2c).
PD-1 induces upregulation of CPT1A and FAO. A critical
pathway targeted by PD-1 is the PI3K/Akt pathway26,27.
Inhibition of the PI3K/Akt pathway by growth factor
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Figure 1 | PD-1 inhibits transport and utilization of glucose during T-cell activation. CD4þ primary human T cells were either left unstimulated (UT) or
were incubated with magnetic beads conjugated with aCD3/aCD28/IgG (Tcells co-stimulated (TCC)) or magnetic beads conjugated with aCD3/aCD28/
PD-L1-Ig fusion protein (T cells co-stimulatedþ PD-1 (TCCþ PD1)). (a) IFN-g production was assessed by ELISA (*Po0.05 TCCþ PD1 versus TCC; n¼ 3
experiments; Student’s t-test). (b,c) Expression of Glut1 after culture under the indicated conditions and time intervals was examined by ﬂow cytometry,
and glucose uptake was examined by 2-{14C(U)}-deoxy-D-glucose incorporation. At each time point glucose uptake in TCCþ PD1-stimulated cells was
compared with TCC-stimulated cells (*Po0.05, TCCþ PD1 versus TCC; n¼ 3 experiments; Student’s t-test). (d) Analysis of key metabolites involved in
glycolysis was performed in cells and culture supernatants as described in Methods. The amounts of the indicated metabolites in unstimulated, TCC and
TCCþ PD1 cells were plotted in whisker boxes. The lower and upper sides of the box indicate the ﬁrst and third quartile, respectively. The horizontal line
inside the box indicates the median value, whereas the lower and upper bars indicate the minimum and maximum of distribution, respectively; (þ ) mean
value; (o) extreme data point. Results of ﬁve measurements generated from ﬁve independent experiments (*Po0.05, TCCþ PD1 versus TCC, Welch’s t-test;
~Po0.05, TCC versus UTand TCCþ PD1 versus UT, analysis of variance). (e) HK2 mRNA was analysed by real-time quantitative PCR and relative expression
of mRNA of each time point and culture condition over the levels expressed in unstimulated cells (deﬁned as 1) is shown. Analysis was performed over
prolonged time of culture (120 h) to investigate whether quantitative difference versus altered kinetics of HK2 expression was induced by PD-1 (*Po0.05,
TCCþ PD1 versus TCC, Student’s t-test; n¼ 3 experiments).
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deprivation in haematopoietic cells activates lipid metabolism
through induction of CPT1A28, the rate-limiting enzyme of
mitochondrial FAO, which plays an important role in the
utilization of fatty acids as an energy source. We investigated
whether PD-1 might regulate utilization of fatty acids as an
alternative energy source. Primary T cells expressed low levels of
CPT1A messenger RNA (mRNA), which were rapidly increased
by 6 h on stimulation via TCR/CD3 and CD28 in the presence or
in the absence of PD-1 ligation. However, the increase of CPT1A
mRNA was transient in TCC cells, while in TCCþ PD1 cells CPT1A
mRNA became persistently and progressively elevated compared
with unstimulated T cells and TCC cells (Fig. 3a). Furthermore,
the abundance of CPT1A protein was diminished on T-cell
stimulation via TCR/CD3 and CD28 but was increased by PD-1
(Fig. 3b). We tested whether PD-1 might affect the rate of FAO
and determined that unstimulated T cells displayed a baseline rate
of FAO, which was decreased by stimulation via TCR/CD3 and
CD28 but was upregulated by PD-1 (Fig. 3c).
PD-1 induces lipolysis and b-oxidation of endogenous fatty acids.
Metabolite analysis showed that TCC and their culture supernatants
had lower quantities of free fatty acids compared with unstimulated
cells (Fig. 4a, Supplementary Fig. 3 and Supplementary Data 1 and
2). These changes were likely due to growth of TCC cells, which
resulted in greater utilization of free fatty acids for lipid synthesis,
incorporation into membrane phospholipids and lipid-based post-
translational modiﬁcation of proteins. Consistent with anabolic
lipid metabolism there was also an increase of the fatty acid
synthase (FASN) in TCC cells (Fig. 4b). Conversely, TCCþPD1 had a
small but reproducible increase of several fatty acids compared with
unstimulated cells, and signiﬁcantly higher levels of fatty acids
compared with TCC cells (Fig. 4a, Supplementary Fig. 3 and
Supplementary Data 1 and 2). We hypothesized that this might be
due to the absence of cell growth and utilization of fatty acids for
incorporation into membrane phospholipids and lipid-based post-
translational modiﬁcation of proteins because there was no evidence
of active lipid synthesis as the induction of FASN was abrogated in
TCCþPD1 cells (Fig. 4b). However, we also observed that TCCþPD1
culture supernatants had increased amounts of the lipolysis marker
glycerol (Supplementary Data 2) and TCCþPD1 cells had increased
amounts of glycerol-3-phosphate, which is generated after phos-
phorylation of glycerol by glycerol kinase (Fig. 4a), suggesting that
PD-1 might induce release of fatty acids from intracellular TG
stores. There was also signiﬁcant elevation of free fatty acids in the
culture supernatants (Fig. 4a and Supplementary Data 2).
To examine whether PD-1 might actively promote TG
lipolysis, we examined the expression of desnutrin/ATGL, a
patatin-domain-containing protein identiﬁed as the major TG
hydrolase in multiple cell types29–32. Activation of T cells resulted
in slight but reproducible decrease of ATGL compared with
unstimulated cells (Fig. 4b,c). In contrast, ligation of PD-1
augmented the abundance of ATGL (Fig. 4b,c), suggesting that
PD-1 might promote lipolysis and availability of endogenously
released fatty acids for FAO.
To investigate this experimentally, we incubated T cells in the
presence of 3H-labelled palmitate for 48 h, over which time the
radiolabelled fatty acid was used to generate cellular lipids.
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Figure 2 | PD-1 inhibits transport and catabolism of glutamine and branched-chain amino acids during T-cell activation. (a) SNAT1 and SNAT2 mRNA
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Subsequently, cells were stimulated by the TCC or TCCþPD1
protocol. Measurement of the rate of FAO at various time
intervals by assessing 3H2O, the end product of b-oxidation from
radiolabelled fatty acids generated from endogenous lipid,
revealed a continuous increase of 3H2O in T cells stimulated
with simultaneous PD-1 ligation. In contrast, T cells stimulated
without PD-1 displayed a decrease of b-oxidation of endogenous
fatty acids, as determined by low levels of 3H2O that declined
steadily (Fig. 4d). Consistent with the increased rate of FAO,
PD-1 induced a signiﬁcant elevation of the ketone body
3-hydroxybutyrate (Fig. 4a and Supplementary Fig. 3), which is
produced during FAO. Thus, PD-1 ligation leads to increase of
FAO, which coincides with upregulation of ATGL, lipolysis and
utilization of endogenous fatty acids for b-oxidation.
Substantial mitochondrial SRC on PD-1 ligation. To investigate
how cellular metabolism of CD4þ primary human T cells is
regulated during stimulation via TCR/CD3 and CD28 and to
determine the role of PD-1, we measured bioenergetic proﬁles.
Extracellular acidiﬁcation rate (ECAR), an indicator of glycolysis,
and oxygen consumption rate (OCR), an indicator of OXPHOS,
were increased in TCC in comparison to unstimulated primary
T cells (Fig. 5a,b), indicating that activated human CD4þ T cells
use both glycolysis and OXPHOS, consistent with previous
observations in mouse CD4þ T cells13. TCCþPD1 showed lower
basal ECAR and OCR (Fig. 5a,b) but had a higher OCR/ECAR
ratio compared with TCC (Fig. 5c). These ﬁndings indicated
that in contrast to proliferating T cells, which preferentially use
glycolysis for energy production, TCCþPD1 cells are rather
metabolically quiescent and preferentially use OXPHOS than
glycolysis as indicated by the higher OCR/ECAR ratio. However,
after use of FCCP to uncouple ATP synthesis from the
electron transport chain, TCCþPD1 demonstrated substantial
mitochondrial SRC as indicated by the difference between the
maximal OCR after FCCP injection and basal OCR, which was
higher than the SRC of TCC and of naı¨ve cells (Fig. 5d,e). This was
surprising because elevated CPT1A expression and CPT1A-
mediated increased SRC are critical regulators of memory
T-cell metabolism, survival and function33. SRC is the extra
mitochondrial capacity available in a cell to produce energy under
conditions of increased work or stress and is thought to be
important for long-term cell survival34. Thus, T cells receiving
PD-1 signals have bioenergetic properties of long-lived cells.
Effects of PD-1 on TCR signaling impact on metabolism. PI3K/
Akt and MEK/Erk pathways have important roles in glucose
metabolism11,12,35. Both pathways are targets of PD-1 (refs
19,27). We examined whether inhibition of these pathways might
recapitulate the effects of PD-1 on altering the metabolic
reprogramming of activated primary T cells by inhibiting
glycolysis and promoting FAO. We used LY294002, a selective
inhibitor of PI3K, and UO126, a selective inhibitor of MEK1/2
kinases. Incubation with LY294002 prevented the decrease of
CPT1A induced by anti-CD3 and anti-CD28 (Fig. 6a). The
decrease of FAO induced on activation was also prevented,
resulting in a rate of FAO comparable to unstimulated T cells
(Fig. 6b). Incubation with UO126 had similar effects (Fig. 6a,c).
Thus inhibition of either PI3K/Akt or MEK/Erk alone, did not
fully recapitulate the effects of PD-1, which upregulated both the
expression of CPT1A and the rate of FAO. In contrast,
simultaneous inhibition of PI3K/Akt and MEK/Erk resulted in
increased abundance of CPT1A (Fig. 6a) but also elevated rate of
FAO above baseline (Fig. 6d), similar to the effects induced by
PD-1. These effects were speciﬁc because the use of vehicle
control or SB203580, a selective inhibitor of p38 MAPK, did not
affect CPT1A expression and FAO (Supplementary Fig. 4a,b).
Furthermore, blockade of PD-1 signiﬁcantly restored Akt and
Erk1/2 activation and reduced FAO (Supplementary Fig. 4c,d).
Assessment of bioenergetics showed that inhibition of either
PI3K/Akt or MEK/Erk suppressed both glycolysis and OXPHOS
as determined by diminished ECAR and OCR but promoted
preferential OXPHOS utilization as determined by increased
OCR/ECAR ratio compared with cells stimulated via TCR/CD3
and CD28 (Supplementary Fig. 5). Concomitantly with the
suppression of the glycolytic phenotype, inhibition of PI3K/Akt
or MEK/Erk, and more prominently the combined inhibition of
PI3K/Akt and MEK/Erk, resulted in increased SRC (Fig. 6e).
Incubation with either LY294002 or UO126 alone did not
increase the levels of ATGL but the combination of
LY294002þUO126 induced ATGL upregulation (Fig. 6f),
suggesting that the elevated rate of FAO during simultaneous
pharmacologic inhibition of PI3K/Akt and MEK/Erk coincided
with increased lipolysis and availability of fatty acids for FAO.
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Figure 3 | PD-1 induces upregulation of CPT1A and fatty acid b-oxidation.
(a) CPT1A mRNA was analysed by real-time quantitative PCR and relative
expression of mRNA of each time point and culture condition over the
levels expressed in unstimulated cells (deﬁned as 1) is shown (*Po0.05,
TCCþ PD1 versus TCC, Student’s t-test; ~Po0.05, TCCþ PD1 versus UT and
TCC versus UT, analysis of variance (ANOVA); n¼ 3 experiments).
(b) CD4þ primary human T cells were cultured under the indicated
conditions. Cell lysates were prepared at the indicated time points and
expression of CPT1A and b-actin were assessed by SDS–PAGE and
immunoblot. Results are representative of three experiments. (c) Fatty acid
b-oxidation rate after culture under the indicated conditions for various
time intervals was examined. Values of TCC and TCCþ PD1 cells were
compared with unstimulated (UT) cells (~Po0.05, ANOVA; n¼ 3) and
values of TCCþ PD1 were compared with TCC cells (*Po0.05, Student’s
t-test; n¼ 3).
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CTLA-4 inhibits glycolytic metabolism without enhancing FAO.
CTLA-4 is another critical T-cell inhibitor of the B7/CD28
superfamily. We examined whether engagement of CTLA-4
would have similar implications on metabolic reprogramming
of T cells, as PD-1. We used a CTLA-4 agonist antibody that
mediates inhibitory effects on T cells when conjugated on tosyl-
activated magnetic beads together with anti-CD3 antibodies
with or without anti-CD28 (ref. 36). First, we examined
expression of Glut1, which is induced on T-cell stimulation
and is a key determinant of glycolytic metabolism. CTLA-4
engagement inhibited Glut1 expression (Fig. 7a), and this
was even more pronounced than the inhibition of Glut1
induced by PD-1 (Fig. 1b). Induction of HK2, the rate-limiting
enzyme of glycolysis, was also diminished (Fig. 7b). As a
consequence, T cells receiving CTLA-4 signals did not activate
glycolytic metabolism, as determined by lack of lactate elevation
(Fig. 7h). CTLA-4 also suppressed the expression of the
glutamine transporters SNAT1 and SNAT2 (Fig. 7c,d),
indicating the uptake and, therefore, metabolism of glutamine
were not activated. Although these effects were comparable
with those induced by PD-1, CTLA-4 mediated a distinct
effect on the regulators of lipid metabolism CPT1A and
ATGL. Compared with baseline, CPT1A and ATGL mRNA
displayed a small, transient increase, (Fig. 7e,f) but these
elevated mRNAs did not reach the magnitude or the persistence
induced by PD-1 ligation (compare Fig. 7e,f with Figs 3a and 4c).
Furthermore, ligation of CTLA-4 did not result in detectable
changes in the rate of FAO as compared with unstimulated cells
(Fig. 7g) and there was no detectable increase of 3-hydro-
xybutyrate in the culture supernatants (Fig. 7i). These results
indicate that, in contrast to PD-1, engagement of CTLA-4
does not imprint a pattern of altered metabolic reprogramming
but rather preserves the metabolic proﬁle of unstimulated
T cells.
PD-1 switches the glycolytic programme of pre-activated T cells.
PD-1 is considered an activation-induced surface molecule
because it is not easily detected in resting T cells but is maximally
expressed by 48 h of activation. However, effects of PD-1 ligation
can be observed by adding PD-L1-Ig fusion protein as early as a
few hours after activation or even at the initiation of the culture,
suggesting that functional levels of PD-1 might be expressed very
early after T-cell activation. To examine whether PD-1-mediated
metabolic reprogramming might be related to the distinct levels of
PD-1 expression at different time points of T-cell activation, ﬁrst
we performed a detailed analysis of PD-1 kinetics of surface
protein expression at 2, 4, 8 and 24 h post stimulation and
subsequently we engaged PD-1 and examined its effects on
T-cell metabolism. Consistent with a previous similarly detailed
analysis37, we detected only minimal PD-1 surface expression
until 8 h of culture, which slightly increased at 24 h, peaked at 48 h
and subsequently declined (Supplementary Fig. 6). Because
comparable PD-1 expression was detected during 2–8 h of
culture, we pre-activated T cells for 4 or 24 h and subsequently
re-cultured them in the presence of PD-L1-Ig and examined
effects on metabolism.
After 4 h of pre-activation, there was no detectable increase
of Glut 1 expression but PD-1 ligation in these pre-activated
T cells diminished subsequent Glut1 upregulation, as compared
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with control non pre-activated cells stimulated by anti-CD3
and anti-CD28 (Fig. 8a, middle and top panels). Strikingly, a
robust suppression effect on Glut1 was observed in T cells
that had been pre-activated for 24 h, in which Glut1 expression
was already induced (Fig. 8a, bottom panel). Although HK2
mRNA was elevated in 4 h pre-activated T cells, and even
more so in 24 h pre-activated T cells PD-1 ligation diminished
HK2 expression at all time points of re-culture (Fig. 8b).
As a consequence, pre-activated T cells turned off their
glycolytic metabolism, resulting in reduced levels of lactate in
the culture supernatants (Fig. 8e). In contrast, under these
conditions, pre-activated T cells elevated CPT1A expression
(Fig. 8c) and displayed increased rate of FAO and elevated
production of 3-hyroxybutyrate (Fig. 8d,f). Furthermore, PD-1
ligation in pre-activated T cells reversed the decrease of ATGL
and restored its expression to levels higher than in T cells
stimulated with anti-CD3 and anti-CD28 (Supplementary
Fig. 7c). PD-1 also suppressed the expression of the glutamine
transporters SNAT1 and SNAT2 in pre-activated T cells
(Supplementary Fig. 7a,b). These results indicate that PD-1 does
not simply prevent initiation of glycolytic metabolism but
imprints a pattern of metabolic reprogramming that can be
induced even after an initial pre-activation phase in the absence
of PD-1 ligation.
Discussion
In the present study, we examined the effects of PD-1 on the
metabolic programme and bioenergetics of activated CD4þ
T cells. Our ﬁndings revealed that T cells receiving PD-1 signals
were unable to uptake and utilize glucose, branched-chain amino
acids and glutamine but were metabolically active and had an
increased rate of FAO. This event was associated with increased
expression of the major TG hydrolase ATGL and the key enzyme
of FAO CPT1A. These concomitant biochemical and molecular
events resulted in increased availability and utilization of free
fatty acids for energy generation through FAO. Furthermore,
T cells receiving PD-1 signals had increased SRC, the extra
capacity available in cells to produce energy under increased
stress or work, which is associated with cell survival. The
metabolic and bioenergetic properties of PD-1-stimulated T cells
display an unexpected and surprising similarity to those of
memory T cells, which sustain their survival due to catabolic
metabolism of FAO33.
In contrast to PD-1, CTLA-4 did not induce a distinct
metabolic programme but preserved the metabolic proﬁle of non-
stimulated cells. The distinct properties of CTLA-4 and PD-1 in
regulating metabolic reprogramming of T cells might be related to
the differential ability of these receptors to oppose TCR signals.
For example, CTLA-4 mediates a potent inhibition of T-cell
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Figure 7 | CTLA-4 inhibits glycolytic reprogramming without increasing the rate of fatty acid b-oxidation. CD4þ primary human Tcells were either left
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ATGL was analysed by real-time quantitative PCR and relative expression of mRNA of each time point and culture condition over the levels expressed in
unstimulated cells (deﬁned as 1) is shown. (g) Fatty acid b-oxidation rate after culture under the indicated conditions for various time intervals was
examined. (h,i) Analysis of lactate (h) and 3-hyroxybutyrate (i), end metabolites of glycolysis and fatty acid b-oxidation, respectively, was performed in
culture supernatants. (For the studies shown in all panels: *Po0.05, TCCþCTLA4 versus TCC, Student’s t-test; ~Po0.05, TCC versus UT and TCCþCTLA4
versus UT, analysis of variance; n¼ 3 experiments).
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activation and its recruitment at the immunological synapse is
regulated by the strength of the TCR signal38. In contrast, PD-1
can inhibit weak but not strong TCR signals39 and, as a
consequence certain but not all TCR-mediated biochemical
events are blocked19. The selective effects of PD-1 on TCR
proximal signalling might have an active role in the regulation of
a distinct metabolic reprogramming, which also leads to a distinct
functional fate.
Our studies revealed that increase of fatty acids, the substrate of
FAO, as well as generation of the ketone body 3-hyroxybutyrate, a
product of FAO, were observed during T-cell stimulation with
simultaneous ligation of PD-1. Fatty acids are important
metabolic intermediates, because they can either be used for
lipid synthesis and protein modiﬁcation or can be degraded
through mitochondrial b-oxidation for energy generation. Our
biochemical studies and our metabolite analysis revealed that in
the presence of PD-1 ligation, T cells had elevated levels of the
lipolysis marker glycerol and increased abundance of ATGL,
and displayed increased utilization of endogenous lipids for
b-oxidation. In contrast, ATGL was rather reduced in T cells
stimulated without PD-1, and these cells had diminished
utilization of endogenous lipids for b-oxidation.
Recent studies determined that T effector cells have the
capacity to acquire exogenous fatty acids, whereas T-memory
cells do not acquire fatty acids but, instead, synthesize fatty acids
by using glucose-derived carbon. Possibly these fatty acids are
then converted into TGs and cholesterol esters, which undergo
hydrolysis mediated by lysosomal acid lipase (LAL), thereby
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Figure 8 | PD-1 alters the metabolic programme of activated Tcells from glycolysis to FAO. CD4þ human Tcells were pre-activated with anti-CD3-and-
anti-CD28 mAbs for 4 h or for 24 h and subsequently were collected, were left to rest for 3 h and re-cultured with tosyl-activated magnetic beads
conjugated with aCD3/aCD28/PD-L1-Ig (Tpr4hr-PD-1 and Tpr24hr-PD-1). In the same experiment CD4þ T cells without pre-activation were
stimulated with tosyl-activated magnetic beads conjugated with aCD3/aCD28/IgG (TCC) and used as positive control for optimal stimulation without
PD-1. (a) Expression of Glut1 after culture under the indicated conditions and time intervals was examined by ﬂow cytometry. (b,c) mRNA for HK2
and CPT1A was analysed by real-time quantitative PCR and relative expression of mRNA of each time point and culture condition over the levels expressed
in unstimulated cells (deﬁned as 1) is shown. (d) Fatty acid b-oxidation rate after culture under the indicated conditions for various time intervals was
examined. (e,f) Analysis of lactate (e) and 3-hydroxybutyrate (f), end metabolites of glycolysis and fatty acid b-oxidation, respectively, was performed in
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generating free fatty acids for FAO40. In contrast to the ﬁndings
in memory cells, we did not detect increase of LAL in PD-1-
stimulated cells. Instead, LAL was upregulated in T cells
undergoing optimal stimulation and this was inhibited by PD-1
(K.B. and V.A.B., unpublished observations). These ﬁndings
might be consistent with a speciﬁc role of LAL in regulating fatty
acid availability in memory T cells, which have been previously
activated during antigen encounter.
Although previously thought to play a role only in adipocytes
where it releases fatty acids from triacylglycerols stored in lipid
droplets, it is today known that ATGL is widely expressed in
various mammalian cell types41,42. Lipid droplets are present
essentially in all cell types, including those for which energy storage
does not seem to be their main purpose. Lipid droplets, particularly
in nonadipose tissues, undergo dynamic and rapid changes of
formation and degradation43. ATGL-mediated lipolysis also has a
key role in mitochondrial homeostasis by generating PPAR ligands,
which induce PPAR-mediated expression of oxidative genes32,44.
Cellular fatty acids obtained from extracellular sources or
generated by de novo synthesis, require esteriﬁcation to TGs and
subsequent lipolysis by ATGL before initiating signal transduction
to the nucleus43. Because naı¨ve T cells rely on FAO for energy
generation, it is possible that ATGL has a key role in regulating
fatty acid availability for FAO and expression of oxidative genes
under conditions of limited fatty acid uptake and lipid synthesis. In
contrast, LAL is upregulated in activated T cells, which
dramatically increase their ability to uptake fatty acids and to
synthesize lipids, which are subsequently stored as cholesterol
esters and TGs in the lysosomes. Elevated LAL levels might persist
or further increase after the glycolytic metabolism of the effector
phase is turned off and the surviving effectors develop into
memory cells, which relay on FAO but obtain biochemical and
bioenergetic properties distinct from naı¨ve T cells. Further work
will be required to identify the functions of these and possibly other
lipases in the distinct phases of T-cell differentiation.
An intriguing observation of our metabolite analysis was the
signiﬁcant elevation of polyunsaturated fatty acids when T cells
are stimulated with PD-1 ligation. Polyunsaturated fatty acids
such as omega-3 fatty acids are recognized as modulators of
immunity. Although the molecular mechanisms are incompletely
understood, polyunsaturated fatty acids seem to suppress antigen
presentation, T-cell activation and cytokine production45,46.
These fatty acids can also alter composition and organization of
membrane rafts with a consequent impact on the activity of raft-
associated signalling proteins and downstream events47. It will be
important to investigate in future work whether such
polyunsaturated fatty acids are involved in PD-1-mediated cell
intrinsic or cell extrinsic functional effects.
Persistent ligation of PD-1 enforces T-cell exhaustion, a state of
T-cell dysfunction that arises during chronic infections and
cancer48–50. T-cell exhaustion is an active process and can lead to
measurable consequences on T-cell function. For example,
distinct subsets of exhausted T cells exist with different
potentials for recovering function after blockade of the PD-1
pathway. Exhausted T cells with intermediate expression of
PD-1 (PD-1int) cells can be reinvigorated by blockade of the PD-1
pathway, whereas those with high expression of PD-1 (PD-1high
cells) cannot51. It is possible that these distinct subsets of
exhausted T cells may also have different bioenergetic properties
and differential capacity for mitochondrial biogenesis, which may
correlate with SRC, CPT1A and ATGL expression. It is tempting
to speculate that the degree of exhaustion and the ability to
reinvigorate exhausted T cells might depend on the reserve of
lipids, which appear to be the only source of energy generation by
FAO in T cells receiving PD-1 signals. Identiﬁcation of such
distinct bioenergetic proﬁles in exhausted T-cell subsets might
provide new tools to determine the level of T-cell exhaustion. It
may also provide novel targets to reverse exhaustion in addition
to PD-1 blockade. Future studies will address these issues in the
context of PD-1-mediated T-cell exhaustion in vivo.
Based on our ﬁndings it is also possible that PD-1-mediated
inhibitory effects on T-cell function might be related to a more
oxidative environment, potentially due to increased b-oxidation.
Our metabolite analysis showed that although depletion of the
cellular antioxidant glutathione (GSH) was observed in T cells
stimulated in the presence or in the absence of PD-1 ligation,
consistent with the expected increase of reactive oxygen species
on activation52,53, PD-1 ligation resulted in signiﬁcantly
more pronounced decrease in the levels of reduced GSH
(Supplementary Data 1). However, these cells displayed higher
levels of cysteine-GSH disulﬁde and ophthalmate, a GSH-like
product synthesized by the same enzymes. These changes
indicate a higher attempt to increase GSH synthesis, which,
together with the more pronounced decrease in the levels of
reduced GSH, are suggestive of a more oxidative environment in
T cells receiving PD-1 signals. A key mediator of oxidative
detoxiﬁcation is the PPARg coactivator-1a (PGC-1a)54,55.
Induction of PGC-1a during caloric restriction mediates
adaptations to provide a permissive setting for increased
OXPHOS. Such changes include the expression of uncoupling
proteins, which have been associated with decreased oxidation-
induced damage. Importantly, mammalian target of rapamycin, a
target of PD-1 downstream of PI3K/Akt inhibition, has a direct
effect on PGC-1a expression56. Thus, PD-1 might impair
oxidative detoxiﬁcation. Future studies will determine how
PGC-1a is regulated on T-cell activation and whether PD-1
might suppress the expression and function of PGC-1a.
In conclusion our present studies show that PD-1 induces
metabolic reprogramming of TCR-stimulated T cells from
glycolysis to lipolysis and utilization of endogenous free fatty
acids for b-oxidation. This programme provides a means for
survival of T cells receiving PD-1 signals during their reduced
capacity for uptake and utilization of other nutrient classes. These
ﬁndings open new directions for the mechanistic understanding
of the impaired T-cell effector function mediated by PD-1 and
identify novel targets that can be exploited therapeutically to
overcome the implications of PD-1 signalling.
Methods
In vitro T-cell cultures. Leucocytes were obtained from normal healthy blood
donors. Primary CD4þ T cells were isolated by negative selection using the CD4þ
T cell Isolation Kit II from Miltenyi Biotec (Auburn, CA) and cultured at 1:1 ratio
with tosyl-activated magnetic beads (1.5 105 beads per well) conjugated either
with anti-CD3, anti-CD28 mAbs and IgG2a or with anti-CD3, anti-CD28 and
PD-L1-IgG2a (ref. 26). For the preparation of Dynabeads M-450 (Invitrogen)
tosyl-activated magnetic beads the following mAbs were used: anti-CD3 (UCHT1,
R&D Systems, Inc.), anti-CD28 (CD28.2, Biolegend) and either PD-L1-IgG2a
(ref. 39) or control IgG2a (Jackson Immunoresearch Laboratories, West Grove,
PA). About 2 108 magnetic beads were coated with anti-CD3 (8%), anti-CD28
(10%) and either PD-L1-Ig fusion protein or control IgG comprised the remaining
82% of the total protein. All incubations were performed in 0.1M sodium
phosphate buffer for 18 h at 37 C with constant rotation. The beads were then
washed three times and stored at 4 C. DNA synthesis was assessed by [3H]-
thymidine incorporation for the last 16 to 18 h of a 72-h culture. In pre-activation
and subsequent PD-1 ligation experiments, CD4þ T cells were cultured with anti-
CD3-and-anti-CD28 mAbs for the indicated time intervals and subsequently were
collected, were left to rest in culture media for 3 h and re-cultured with tosyl-
activated beads (1.5 105 beads per well) conjugated with anti-CD3, anti-CD28
mAbs and PD-L1-IgG2a. In the same experiment, CD4þ T cells without pre-
activation were cultured with tosyl-activated magnetic beads (1.5 105 beads per
well) conjugated with anti-CD3, anti-CD28 mAbs and IgG2a and were used
as a positive control. When indicated, the blocking anti-PD1 antibody J105
(eBioscience) was used. For studies of CTLA-4-mediated effects on T-cell metabolic
reprogramming, the CTLA-4 antibody 14D3 (eBioscience) was used to coat on
tosyl-activated magnetic beads instead of PD-L-1-Ig. Where indicated, cells were
cultured in the presence of the PI3K inhibitor LY294002 (10 mM), the MEKK
inhibitor UO126 (10 mM), the p38 MAPK inhibitor SB203580 (10mM) or the
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combination of LY294002 and UO126 (all inhibitors from Sigma-Aldrich, St Louis,
MO), using a concentration previously determined to induce target-speciﬁc
inhibition without affecting cell viability57.
Immunoblotting. Cell lysates were prepared as previously mentioned19 and equal
amounts of protein of each sample were analysed by SDS–PAGE. The antibodies
for Glut1 (sc-1603), ATGL (sc-365278) and b-actin (sc-1615) were from Santa
Cruz Biotechnology, Santa Cruz, CA. The anti-FASN (#3189) was from Cell
Signaling Technologies, Danvers, MA, and the anti-CPT1A (#TA303144) antibody
was from OriGene Technologies Inc., Rockville, MD.
Assessment of Glut1 expression by ﬂow cytometry. T cells were stimulated for
the indicated time intervals with bead-linked Abs and ﬁxed overnight at 4 C with
Fixation Buffer (eBioscience). Fixed cells were permeabilized with permeabilization
buffer (eBioscience) and stained with FITC-conjugated anti-Glut1 Ab (R&D Sys-
tems, Inc.). Mouse IgG2b was used as an isotype control. Glut1 staining was
measured by ﬂow cytometry on BD LSRII, and data were analysed with FlowJo
software (Tree Star Inc).
Glucose uptake assay. T cells were cultured at the indicated conditions and then
1 106 cells were starved in PBS at room temperature for 30min followed by
incubation at 37 C for 5min in PBS containing 5 mM 2{14C(U)}-deoxy-D-glucose
(Perkin Elmer, Boston, MA)58. Cells were then harvested on ﬁltermats and counted
for 14C-glucose content.
b-oxidation assay. T cells were cultured at the indicated conditions at 1 106 cells
per ml. Oxidation of fatty acids was measured according to established method28.
Brieﬂy, cells were supplemented with [9,10-3H]palmitate (Perkin Elmer, Boston,
MA) complexed to BSA by vortexing for 1min a mixture of the palmitate and a
10% fatty acid-free BSA (Sigma, St Louis, MO #A8806) solution at a 1:2 volume
ratio. A total of 3.3 ml of [9,10-3H]palmitate (5 mCi ml 1 stock) and 6.7 ml of BSA
were used per 1ml of cell culture medium and cells were cultured in 24-well plates
with or without etomoxir. After 24 h, 0.4ml supernatant was applied to ion-
exchange columns (Dowex 1 8–200, Sigma, #217425), and 3H2O was recovered
by eluting with 1ml of H2O. A 0.4-ml aliquot was then mixed with 1ml
scintillation ﬂuid (Ultima Gold, #6013321, Perkin Elmer) and counted. Cell
number was counted after the collection of each supernatant and the results were
expressed as CPM 103/1 106 cells. To measure utilization of endogenous lipids
as a substrate of FAO, we incubated primary human T cells (40 106) in the
presence of phytohaemaglutinin (10 mgml 1), phorbol myristate (1 ngml 1) and
tritium-labelled palmitate for 48 h. This mixture was prepared by adding 20 mCi of
[9,10-3H]palmitate (5 mCi ml 1 stock) to 1ml of 10 mM unlabelled palmitate stock
in a solution of 10% essentially fatty acid-free BSA into 20ml culture medium for
48 h, over which time the radiolabelled fatty acid was used to generate cellular
lipids. Subsequently, cells were washed to remove unincorporated label and were
stimulated with beads conjugated with anti-CD3, anti-CD28 mAbs and IgG or with
beads conjugated with anti-CD3, anti-CD28 mAbs and PD-L1-Ig fusion protein,
with or without etomoxir. Culture supernatants were collected at various time
intervals and 0.4ml supernatant was applied to ion-exchange columns and
determination of radioactivity was performed as described above.
Metabolism assays. OCR and ECAR were measured according to previously
established protocol33 using XF base media (#102353-100) supplemented with
25mM glucose, 2mM L-glutamine and 1mM sodium pyruvate under basal
conditions, and in response to 1mM oligomycin, 1.5mM ﬂuorocarbonyl cyanide
phenylhydrazone and 100 nM rotenoneþ 1mM antimycin A using the XF Cell
Mito Stress Test Kit on a XF-24 Extracellular Flux Analyzer (Seahorse Bioscience,
North Billerica, MA).
Metabolite analysis. T cells were grown under the indicated culture conditions at
4 106 cells per 6ml per well in six-well culture plates. After 96 h of culture,
30 106 cells and 0.5ml culture supernatants were harvested separately, ﬂash-
frozen in liquid nitrogen and stored at  80 C. A total of ﬁve replicate samples for
each condition generated from ﬁve independent experiments were analysed on Gas
chromatography–mass spectrometry (GC/MS) and liquid chromatography–
tandem mass spectrometry (LC/MS/MS) platforms59,60 by Metabolon Inc.
(Durham, NC), as described below.
Sample accessioning. Each sample received was accessioned into the Metabolon
Laboratory Information Management System (LIMS) and was assigned by the LIMS
a unique identiﬁer, which was associated with the original source identiﬁer only. This
identiﬁer was used to track all sample handling, tasks, results and so on. The samples
(and all derived aliquots) were bar coded and tracked by the LIMS system. All
portions of any sample were automatically assigned their own unique identiﬁers by
the LIMS when a new task was created; the relationship of these samples was also
tracked. All samples were maintained at  80 C until processed.
Sample preparation. The sample preparation process was carried out using the
automated MicroLab STAR system from Hamilton Company. Recovery standards
were added prior to the ﬁrst step in the extraction process for quality control (QC)
purposes. Sample preparation was conducted using a proprietary series of organic
and aqueous extractions to remove the protein fraction, while allowing maximum
recovery of small molecules. The resulting extract was divided into two fractions;
one for analysis by LC and one for analysis by GC. Samples were placed brieﬂy on a
TurboVap (Zymark) to remove the organic solvent. Each sample was then frozen
and dried under vacuum. Samples were then prepared for the appropriate
instrument, either using LC/MS or GC/MS.
Ultra-performance liquid chromatography–tandem mass spectrometry. The
LC/MS portion of the platform was based on a Waters ACQUITY UPLC and a
Thermo-Finnigan LTQ mass spectrometer, which consisted of an electrospray
ionization source and linear ion-trap mass analyser. The sample extract was split
into two aliquots, dried, then reconstituted in acidic or basic LC-compatible
solvents, each of which containedX11 injection standards at ﬁxed concentrations.
One aliquot was analysed using acidic positive ion optimized conditions and the
other using basic negative ion optimized conditions in two independent injections
using separate dedicated columns. Extracts reconstituted in acidic conditions were
gradient eluted using water and methanol both containing 0.1% formic acid, while
the basic extracts, which also used water/methanol, contained 6.5mM ammonium
bicarbonate. The MS analysis alternated between MS and data-dependent MS2
scans using dynamic exclusion.
Gas chromatography/mass spectrometry. The samples destined for GC/MS
analysis were re-dried under vacuum desiccation for a minimum of 24 h prior to
being derivatized under dried nitrogen using bistrimethyl-silyl-triﬂouroacetamide.
The GC column was 5% phenyl and the temperature ramp is from 40 to 300 C in
a 16-min period. Samples were analysed on a Thermo-Finnigan Trace DSQ fast-
scanning single-quadrupole mass spectrometer using electron impact ionization.
The instrument was tuned and calibrated for mass resolution and mass accuracy on
a daily basis. The information output from the raw data ﬁles was automatically
extracted as discussed below.
Data extraction, quality assurance/QC and compound identiﬁcation. The data
extraction of the raw mass spec data ﬁles yielded information that could be loaded
into a relational database. Once in the database, the information was examined and
appropriate QC limits were imposed. Peaks were identiﬁed using Metabolon’s
proprietary peak integration software. Compounds were identiﬁed by comparison
to library entries of puriﬁed standards or recurrent unknown entities. Identiﬁcation
of known chemical entities was based on comparison to metabolomic library
entries of puriﬁed standards.
Statistical calculation. For pair-wise comparisons Welch’s t-test was used.
Analysis of variance was used for comparison of more than two conditions.
Selected metabolites were plotted in whisker boxes.
Real-time qPCR. Total RNA extraction was prepared with the RNeasy Mini Kit
from Qiagen, Valencia, CA, according to the manufacturer’s instructions and
50 ng of RNA was subjected to qPCR analysis as described previously19 for the
target genes HK2, CPT1A, SNAT1, SNAT2 and ATGL. All FAM-conjugated
gene-speciﬁc primers as well as the TaqMan One-Step RT-PCR Master Mix
reagents and the VIC-TAMRA-conjugated 18S RNA housekeeping gene control
primers were from Applied Biosystems/Roche, Branchburg, NJ. The reaction was
performed in a AB 7000 quantitative PCR machine from Applied Biosystems.
Assessment of mitochondrial membrane potential (DWm). Cells were har-
vested, stained in culture medium with TMRE (Sigma-Aldrich) to a ﬁnal con-
centration of 100 nM, and incubated for 30min at 37 C with 5% CO2. CCCP
(Sigma-Aldrich) was added to collapse DCm and therefore to validate the assay and
serve as a control for background levels of ﬂuorescence. Cells were analysed for
TMRE intensity by ﬂow cytometry.
Cytokine production. Culture supernatants were harvested at the indicated time
points and the concentration of IFN-g was assessed by ELISA using the high
sensitivity assay kit (eBioscience, Inc. San Diego, CA) according to the manu-
facturer’s instructions.
Statistical analysis. In vitro assays were compared with the unpaired Student’s
t-test or by analysis of variance for more than two conditions. A P value ofo0.05
was considered statistically signiﬁcant.
References
1. Francisco, L. M., Sage, P. T. & Sharpe, A. H. The PD-1 pathway in tolerance
and autoimmunity. Immunol. Rev. 236, 219–242 (2010).
2. Reynoso, E. D. et al. Intestinal tolerance is converted to autoimmune enteritis
on PD-1 ligand blockade. J. Immunol. 182, 2102–2112 (2009).
3. Probst, H. C., McCoy, K., Okazaki, T., Honjo, T. & van den Broek, M. Resting
dendritic cells induce peripheral CD8þ T cell tolerance through PD-1 and
CTLA-4. Nat. Immunol. 6, 280–286 (2005).
4. Kuang, D. M. et al. Activated monocytes in peritumoural stroma of
hepatocellular carcinoma foster immune privilege and disease progression
through PD-L1. J. Exp. Med. 206, 1327–1337 (2009).
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms7692 ARTICLE
NATURE COMMUNICATIONS | 6:6692 | DOI: 10.1038/ncomms7692 | www.nature.com/naturecommunications 11
& 2015 Macmillan Publishers Limited. All rights reserved.
5. Zhang, L., Gajewski, T. F. & Kline, J. PD-1/PD-L1 interactions inhibit
antitumour immune responses in a murine acute myeloid leukemia model.
Blood 114, 1545–1552 (2009).
6. Day, C. L. et al. PD-1 expression on HIV-speciﬁc T cells is associated with
T-cell exhaustion and disease progression. Nature 443, 350–354 (2006).
7. Barber, D. L. et al. Restoring function in exhausted CD8 T cells during chronic
viral infection. Nature 439, 682–687 (2006).
8. Frauwirth, K. A. & Thompson, C. B. Regulation of T lymphocyte metabolism.
J. Immunol. 172, 4661–4665 (2004).
9. Rathmell, J. C., Vander Heiden, M. G., Harris, M. H., Frauwirth, K. A. &
Thompson, C. B. In the absence of extrinsic signals, nutrient utilization by
lymphocytes is insufﬁcient to maintain either cell size or viability. Mol. Cell 6,
683–692 (2000).
10. Warburg, O. On respiratory impairment in cancer cells. Science 124, 269–270
(1956).
11. Frauwirth, K. A. et al. The CD28 signalling pathway regulates glucose
metabolism. Immunity 16, 769–777 (2002).
12. Wieman, H. L., Wofford, J. A. & Rathmell, J. C. Cytokine stimulation promotes
glucose uptake via phosphatidylinositol-3 kinase/Akt regulation of Glut1
activity and trafﬁcking. Mol. Biol. Cell 18, 1437–1446 (2007).
13. Chang, C. H. et al. Posttranscriptional control of T-cell effector function by
aerobic glycolysis. Cell 153, 1239–1251 (2013).
14. Pearce, E. L. et al. Enhancing CD8 T-cell memory by modulating fatty acid
metabolism. Nature 460, 103–107 (2009).
15. Araki, K. et al. mTOR regulates memory CD8 T-cell differentiation. Nature
460, 108–112 (2009).
16. Zaugg, K. et al. Carnitine palmitoyltransferase 1C promotes cell survival and
tumour growth under conditions of metabolic stress. Genes Dev. 25, 1041–1051
(2011).
17. van der Windt, G. J. & Pearce, E. L. Metabolic switching and fuel choice during
T-cell differentiation and memory development. Immunol. Rev. 249, 27–42
(2013).
18. Wang, M. C., O’Rourke, E. J. & Ruvkun, G. Fat metabolism links germline stem
cells and longevity in C. elegans. Science 322, 957–960 (2008).
19. Patsoukis, N. et al. Selective effects of PD-1 on Akt and Ras pathways regulate
molecular components of the cell cycle and inhibit T cell proliferation. Sci.
Signal. 5, ra46 (2012).
20. Francisco, L. M. et al. PD-L1 regulates the development, maintenance, and
function of induced regulatory T cells. J. Exp. Med. 206, 3015–3029 (2009).
21. Koch, B., Schroder, M. T., Schafer, G. & Schauder, P. Comparison between
transport and degradation of leucine and glutamine by peripheral human
lymphocytes exposed to concanavalin A. J. Cell Physiol. 143, 94–99 (1990).
22. Ardawi, M. S. & Newsholme, E. A. Glutamine metabolism in lymphocytes of
the rat. Biochem. J. 212, 835–842 (1983).
23. Li, P., Yin, Y. L., Li, D., Kim, S. W. & Wu, G. Amino acids and immune
function. Br. J. Nutr. 98, 237–252 (2007).
24. Newsholme, P. et al. Glutamine metabolism by lymphocytes, macrophages, and
neutrophils: its importance in health and disease. J. Nutr. Biochem. 10, 316–324
(1999).
25. Carr, E. L. et al. Glutamine uptake and metabolism are coordinately regulated
by ERK/MAPK during T lymphocyte activation. J. Immunol. 185, 1037–1044
(2010).
26. Patsoukis, N., Li, L., Sari, D., Petkova, V. & Boussiotis, V. A. PD-1 increases
PTEN phosphatase activity while decreasing PTEN protein stability by
inhibiting casein kinase 2. Mol. Cell Biol. 33, 3091–3098 (2013).
27. Parry, R. V. et al. CTLA-4 and PD-1 receptors inhibit T-cell activation by
distinct mechanisms. Mol. Cell Biol. 25, 9543–9553 (2005).
28. Deberardinis, R. J., Lum, J. J. & Thompson, C. B. Phosphatidylinositol 3-kinase-
dependent modulation of carnitine palmitoyltransferase 1A expression
regulates lipid metabolism during haematopoietic cell growth. J. Biol. Chem.
281, 37372–37380 (2006).
29. Duncan, R. E. et al. Characterization of desnutrin functional domains: critical
residues for triacylglycerol hydrolysis in cultured cells. J. Lipid Res. 51, 309–317
(2010).
30. Villena, J. A., Roy, S., Sarkadi-Nagy, E., Kim, K. H. & Sul, H. S. Desnutrin, an
adipocyte gene encoding a novel patatin domain-containing protein, is induced
by fasting and glucocorticoids: ectopic expression of desnutrin increases
triglyceride hydrolysis. J. Biol. Chem. 279, 47066–47075 (2004).
31. Jenkins, C. M. et al. Identiﬁcation, cloning, expression, and puriﬁcation of three
novel human calcium-independent phospholipase A2 family members
possessing triacylglycerol lipase and acylglycerol transacylase activities. J. Biol.
Chem. 279, 48968–48975 (2004).
32. Zimmermann, R. et al. Fat mobilization in adipose tissue is promoted by
adipose triglyceride lipase. Science 306, 1383–1386 (2004).
33. van der Windt, G. J. et al. Mitochondrial respiratory capacity is a critical
regulator of CD8þ T cell memory development. Immunity 36, 68–78 (2012).
34. Nicholls, D. G. Spare respiratory capacity, oxidative stress and excitotoxicity.
Biochem. Soc. Trans. 37, 1385–1388 (2009).
35. Marko, A. J., Miller, R. A., Kelman, A. & Frauwirth, K. A. Induction of glucose
metabolism in stimulated T lymphocytes is regulated by mitogen-activated
protein kinase signalling. PLoS ONE 5, e15425 (2010).
36. Vandenborre, K. et al. Interaction of CTLA-4 (CD152) with CD80 or CD86
inhibits human T-cell activation. Immunology 98, 413–421 (1999).
37. Chemnitz, J. M., Parry, R. V., Nichols, K. E., June, C. H. & Riley, J. L. SHP-1
and SHP-2 associate with immunoreceptor tyrosine-based switch motif of
programmed death 1 on primary human T-cell stimulation, but only receptor
ligation prevents T-cell activation. J. Immunol. 173, 945–954 (2004).
38. Egen, J. G., Kuhns, M. S. & Allison, J. P. CTLA-4: new insights into its
biological function and use in tumour immunotherapy. Nat. Immunol. 3,
611–618 (2002).
39. Latchman, Y. et al. PD-L2 is a second ligand for PD-1 and inhibits T-cell
activation. Nat. Immunol. 2, 261–268 (2001).
40. O’Sullivan, D. et al. Memory CD8(þ ) T cells use cell-intrinsic lipolysis to
support the metabolic programmeming necessary for development. Immunity
41, 75–88 (2014).
41. Schoenborn, V. et al. The ATGL gene is associated with free fatty acids,
triglycerides, and type 2 diabetes. Diabetes 55, 1270–1275 (2006).
42. Smirnova, E. et al. ATGL has a key role in lipid droplet/adiposome degradation
in mammalian cells. EMBO Rep. 7, 106–113 (2006).
43. Zechner, R. et al. FAT SIGNALS--lipases and lipolysis in lipid metabolism and
signalling. Cell Metab. 15, 279–291 (2012).
44. Tang, T. et al. Desnutrin/ATGL activates PPARdelta to promote mito-
chondrial function for insulin secretion in islet beta cells. Cell Metab. 18,
883–895 (2013).
45. Jaudszus, A. et al. Evaluation of suppressive and pro-resolving effects of EPA
and DHA in human primary monocytes and T-helper cells. J. Lipid Res. 54,
923–935 (2013).
46. Petursdottir, D. H. & Hardardottir, I. Dietary ﬁsh oil decreases secretion
of T helper (Th) 1-type cytokines by a direct effect on murine splenic T cells but
enhances secretion of a Th2-type cytokine by an effect on accessory cells. Br. J.
Nutr. 101, 1040–1046 (2009).
47. Shaikh, S. R., Jolly, C. A. & Chapkin, R. S. n-3 Polyunsaturated fatty acids exert
immunomodulatory effects on lymphocytes by targeting plasma membrane
molecular organization. Mol. Aspects Med. 33, 46–54 (2011).
48. Crawford, A. et al. Molecular and transcriptional basis of CD4(þ ) T cell
dysfunction during chronic infection. Immunity 40, 289–302 (2014).
49. Wherry, E. J. et al. Molecular signature of CD8þ T-cell exhaustion during
chronic viral infection. Immunity 27, 670–684 (2007).
50. Wherry, E. J. T-cell exhaustion. Nat. Immunol. 12, 492–499 (2011).
51. Blackburn, S. D., Shin, H., Freeman, G. J. & Wherry, E. J. Selective expansion of
a subset of exhausted CD8 T cells by alphaPD-L1 blockade. Proc. Natl Acad.
Sci. USA 105, 15016–15021 (2008).
52. Kaminski, M. M. et al. T-cell activation is driven by an ADP-dependent
glucokinase linking enhanced glycolysis with mitochondrial reactive oxygen
species generation. Cell Rep. 2, 1300–1315 (2012).
53. Kaminski, M. M. et al. Mitochondrial reactive oxygen species control
T-cell activation by regulating IL-2 and IL-4 expression: mechanism of
ciproﬂoxacin-mediated immunosuppression. J. Immunol. 184, 4827–4841
(2010).
54. Bhalla, K. et al. PGC1alpha promotes tumour growth by inducing gene
expression programs supporting lipogenesis. Cancer Res. 71, 6888–6898 (2011).
55. St-Pierre, J. et al. Suppression of reactive oxygen species and neurodegeneration
by the PGC-1 transcriptional coactivators. Cell 127, 397–408 (2006).
56. Cunningham, J. T. et al. mTOR controls mitochondrial oxidative function
through a YY1-PGC-1alpha transcriptional complex. Nature 450, 736–740
(2007).
57. Appleman, L. J., van Puijenbroek, A. A., Shu, K. M., Nadler, L. M. & Boussiotis,
V. A. CD28 costimulation mediates down-regulation of p27kip1 and cell cycle
progression by activation of the PI3K/PKB signalling pathway in primary
human T cells. J. Immunol. 168, 2729–2736 (2002).
58. Barata, J. T. et al. Activation of PI3K is indispensable for interleukin 7-mediated
viability, proliferation, glucose use, and growth of T cell acute lymphoblastic
leukemia cells. J. Exp. Med. 200, 659–669 (2004).
59. Evans, A. M., DeHaven, C. D., Barrett, T., Mitchell, M. & Milgram, E.
Integrated, nontargeted ultrahigh performance liquid chromatography/
electrospray ionization tandem mass spectrometry platform for the
identiﬁcation and relative quantiﬁcation of the small-molecule complement of
biological systems. Anal. Chem. 81, 6656–6667 (2009).
60. Reitman, Z. J. et al. Proﬁling the effects of isocitrate dehydrogenase 1 and 2
mutations on the cellular metabolome. Proc. Natl Acad. Sci. USA 108,
3270–3275 (2011).
Acknowledgements
This work was supported by NIH grants CA183605 and AI098129 (to V.A.B.) and
AI056299 and HHSN2722018C (to G.J.F.).
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms7692
12 NATURE COMMUNICATIONS | 6:6692 | DOI: 10.1038/ncomms7692 | www.nature.com/naturecommunications
& 2015 Macmillan Publishers Limited. All rights reserved.
Author contributions
N.P., K.B., P.C., D.S., B.L., L.L. and V.A.B. performed experiments in various aspects of the
project; V.P. assisted with qPCR experiments; G.J.F. provided PD-L1-IgG2 fusion protein;
L.N.B. and E.D.K. performed metabolite analysis; P.S. assisted with the bioenergetics studies;
V.A.B. guided the studies; all authors contributed to the preparation of the manuscript.
Additional information
Supplementary Information accompanies this paper at http://www.nature.com/
naturecommunications
Competing ﬁnancial interests: G.J.F. receives royalties from patents related to PD-1
pathway. The other authors declare that they have no competing interests.
Reprints and permission information is available online at http://npg.nature.com/
reprintsandpermissions/
How to cite this article: Patsoukis, N. et al. PD-1 alters T-cell metabolic reprogramming
by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation. Nat. Commun.
6:6692 doi: 10.1038/ncomms7692 (2015).
This work is licensed under a Creative Commons Attribution 4.0
International License. The images or other third party material in this
article are included in the article’s Creative Commons license, unless indicated otherwise
in the credit line; if the material is not included under the Creative Commons license,
users will need to obtain permission from the license holder to reproduce the material.
To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms7692 ARTICLE
NATURE COMMUNICATIONS | 6:6692 | DOI: 10.1038/ncomms7692 | www.nature.com/naturecommunications 13
& 2015 Macmillan Publishers Limited. All rights reserved.
